Acute Musculoskeletal Injury Management

Introduction to Topical Diclofenac with Menthol

• Topical diclofenac with menthol gel is highly recommended as first-line therapy for acute musculoskeletal injuries, providing superior symptom relief compared to other interventions with minimal systemic adverse effects, as recommended by the American College of Physicians and American Academy of Family Physicians 1, 2

Efficacy of Topical Diclofenac with Menthol

• Low-certainty evidence shows significant improvement in symptom relief with topical NSAIDs plus menthol gel (OR, 13.34 [CI, 3.30 to 53.92]) compared to placebo 1
• For pain reduction at less than 2 hours, moderate-certainty evidence shows topical NSAIDs plus menthol gel reduces pain (WMD, −1.68 cm [CI, −3.09 to −0.27 cm]) on a 10-cm visual analog scale 1
• Topical diclofenac with menthol is among the most effective interventions for acute pain reduction in the first 2 hours 1
• High-certainty evidence shows topical NSAIDs provide significantly more treatment satisfaction than placebo (OR, 5.20 [CI, 2.03 to 13.33]) 1

Recommendations for Use

• The American College of Physicians and American Academy of Family Physicians recommend topical NSAIDs with or without menthol gel as first-line therapy for acute musculoskeletal injuries other than low back pain 1, 2
• Topical diclofenac with menthol is particularly effective for acute musculoskeletal injuries such as sprains, whiplash, and muscle strains 1, 2
• Patients with risk factors for systemic NSAID adverse effects (cardiovascular, gastrointestinal, or renal comorbidities) may benefit from topical diclofenac with menthol 2
• The American College of Sports Medicine recommends applying topical diclofenac 3-4 times daily to the affected area, with specific formulations including gel (1-4%), patch (180 mg), or spray gel (4%) depending on the location and extent of pain 3

Safety Profile

• No statistically significant increase in gastrointestinal adverse events compared to placebo (moderate-certainty evidence) 1
• Dermatologic adverse events did not differ significantly from placebo (high-quality data) 1
• Very few systemic adverse events (high-quality data) 1
• Topical NSAIDs provided the greatest benefit-harm ratio for musculoskeletal injuries 2
• Contraindications for topical diclofenac include broken or damaged skin, and avoidance of contact with eyes and mucous membranes 3

Comparison to Other Pain Relief Options

• Topical diclofenac formulations are more effective than placebo and comparable to oral NSAIDs with fewer systemic side effects, although specific comparisons may vary 1, 2
• Compared to oral NSAIDs, topical diclofenac has a lower risk of gastrointestinal adverse events (OR, 1.77 [CI, 1.33 to 2.35]) and is recommended for patients with cardiovascular disease, renal impairment, or gastrointestinal risk factors 1, 4
• The following table summarizes the efficacy of oral and topical diclofenac:

• Oral diclofenac (50-75 mg 2-3 times daily) may be considered for widespread or diffuse muscle pain, pain not adequately controlled with topical application, or situations where topical application is impractical, but should be used with caution due to increased risk of gastrointestinal adverse events 1, 4
• Combination therapy with acetaminophen plus oral diclofenac may be considered for enhanced symptom relief 1, 5

Treatment Duration and Considerations

• Treatment duration for acute muscle pain is 7-14 days, while for chronic muscle pain, periodic use as needed is recommended, with breaks between treatment courses to assess continued need 3
• Consider topical NSAIDs (including diclofenac) for localized muscle pain due to high treatment satisfaction, good symptom relief, and minimal systemic adverse effects 1, 5
• Oral NSAIDs (including diclofenac) can be considered for more diffuse muscle pain or when topical application is impractical 1, 5